Division of Geriatric Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, PA 15213, USA.
J Am Med Dir Assoc. 2011 Jun;12(5):377-83. doi: 10.1016/j.jamda.2010.04.008. Epub 2010 Oct 2.
Inappropriate prescribing of primarily renally cleared medications in older patients with kidney disease can lead to adverse outcomes.
To estimate the prevalence of potentially inappropriate prescribing of 21 primarily renally cleared medications based on 2 separate estimates of renal function and to identify factors associated with this form of suboptimal prescribing in older VA nursing home (NH) patients.
Longitudinal study
Participants were 1304 patients, aged 65 years or older, admitted between January 1, 2004, and June 30, 2005, for 90 days or more to 1 of 133 VA NHs.
Potentially inappropriate prescribing of primarily renally cleared medications determined by estimating creatinine clearance using the Cockcroft Gault (CG) and Modification of Diet in Renal Disease (MDRD) equations and applying explicit guidelines for contraindicated medications and dosing.
The median estimated creatinine clearance via CG was 67 mL/min, whereas it was 80 mL/min/1.73m(2) with the MDRD. Overall, 11.89% patients via CG and only 5.98% via MDRD had evidence of potentially inappropriate prescribing of at least 1 renally cleared medication. The most commonly involved medications were ranitidine, glyburide, gabapentin, and nitrofurantoin. Factors associated with potentially inappropriate prescribing as per the CG were age older than 85 (adjusted odds ratio [AOR] 4.24, 95% confidence interval [CI] 2.42-7.43), obesity (AOR 0.26, 95% CI 0.14-0.50) and having multiple comorbidities (AOR 1.09 for each unit increase in the Charlson comorbidity index, 95% CI 1.01-1.19).
Potentially inappropriate prescribing of renally cleared medications is common in older VA NH patients. Intervention studies to improve the prescribing of primarily renally cleared medications in nursing homes are needed.
在患有肾脏疾病的老年患者中,主要经肾脏清除的药物的不当处方可能导致不良后果。
根据两种独立的肾功能估计值,估算 21 种主要经肾脏清除的药物潜在不适当处方的发生率,并确定与老年退伍军人事务部(VA)护理院(NH)患者这种形式的次优处方相关的因素。
纵向研究
参与者为 1304 名年龄在 65 岁或以上的患者,他们于 2004 年 1 月 1 日至 2005 年 6 月 30 日期间入住 133 个 VA NH 中的 1 个,住院时间为 90 天或以上。
通过使用 Cockcroft-Gault(CG)和肾脏病饮食修正公式(MDRD)估计肌酐清除率,并应用明确的禁忌药物和剂量指南来确定主要经肾脏清除的药物的潜在不适当处方。
通过 CG 估计的中位肌酐清除率为 67 mL/min,而通过 MDRD 则为 80 mL/min/1.73m²。总体而言,11.89%的患者通过 CG 有证据表明至少有 1 种经肾脏清除的药物处方不当,而只有 5.98%的患者通过 MDRD 有证据表明至少有 1 种经肾脏清除的药物处方不当。涉及的最常见药物为雷尼替丁、格列本脲、加巴喷丁和呋喃妥因。根据 CG,与潜在不适当处方相关的因素包括年龄大于 85 岁(调整后的优势比[OR] 4.24,95%置信区间[CI] 2.42-7.43)、肥胖(OR 0.26,95%CI 0.14-0.50)和存在多种合并症(Charlson 合并症指数每增加 1 个单位,OR 为 1.09,95%CI 1.01-1.19)。
在老年 VA NH 患者中,主要经肾脏清除的药物的潜在不适当处方很常见。需要开展干预研究以改善护理院中主要经肾脏清除的药物的处方。